Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro

JOURNAL FOR IMMUNOTHERAPY OF CANCER

Ledererova, A; Dostalova, L; Kozlova, V; Peschelova, H; Ladungova, A; Culen, M; Loja, T; Verner, J; Pospisilova, S; Smida, M; Mancikova, V, 2021: Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro. JOURNAL FOR IMMUNOTHERAPY OF CANCER 9(8), doi: 10.1136/jitc-2021-002352

Research Groups:

Functional Genomics
Medical Genomics

CEITEC authors:

Aneta Ledererová
Lenka Dostálová
Adriana Ladungová
Tomáš Loja, Ph.D.
Jan Verner, Ph.D.
Michal Šmída